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Canonical Wnt signaling in endothelial cells (ECs) is
required for vascularizationof thecentral nervoussys-
tem (CNS) and for formation and maintenance of bar-
rier properties unique to CNS vasculature. Gpr124 is
an orphanmember of the adhesionGprotein-coupled
receptor family that is expressed in ECs and is essen-
tial for CNS angiogenesis and barrier formation via an
unknown mechanism. Using canonical Wnt signaling
assays in cell culture and genetic loss- and gain-of-
function experiments in mice, we show that Gpr124
functions as a coactivator ofWnt7a- andWnt7b-stim-
ulated canonical Wnt signaling via a Frizzled receptor
and Lrp coreceptor and that Gpr124-stimulated
signaling functions in concert with Norrin/Frizzled4
signaling to control CNS vascular development.
These experiments identify Gpr124 as a ligand-spe-
cific coactivator of canonical Wnt signaling.
INTRODUCTION
Central nervous system (CNS) angiogenesis begins with endo-
thelial cell (EC) invasion from the perineural vascular plexus, fol-
lowed by EC migration and vascular branching within the CNS.
Concomitant with development of the CNS vasculature, brain
ECs acquire the characteristics of a blood-brain barrier (BBB)
(or in the eye, a blood-retina barrier [BRB]). Canonical Wnt
signaling plays a central role in these processes. In the embryo,
Wnt7a andWnt7b produced by the neuroepithelium of the devel-
oping brain and spinal cord promote angiogenesis and BBB for-
mation by activating canonical Wnt signaling in ECs (Stenman
et al., 2008; Liebner et al., 2008; Daneman et al., 2009). In the
postnatal retina and cerebellum, an analogous response ismedi-
ated by glial-derived Norrin (a transforming growth factor b family
member), which activates canonical Wnt signaling in ECs via the
receptor Frizzled4 (Fz4) and coreceptors Lrp5 and Lrp6 (Xu et al.,
2004; Ye et al., 2009; Wang et al., 2012). In retinal ECs, the cell-
surface Norrin/Fz4/Lrp5 signaling complex also includes the
tetra-spanin protein Tspan12 (Junge et al., 2009). In humans
and mice, mutations in the genes coding for each of these poly-248 Developmental Cell 31, 248–256, October 27, 2014 ª2014 Elsevpeptides cause retinal hypovascularization syndromes that
impair or eliminate vision (Nikopoulos et al., 2010; Ye et al.,
2010).
Gpr124, amember of the ‘‘adhesionG-protein-coupled recep-
tor (GPCR)’’ family, was first linked to vascular biology based on
the enrichment of its transcripts in human colorectal tumor
vasculature (St. Croix et al., 2000; Carson-Walter et al., 2001;
Gpr124 is also referred to as tumor endothelial marker 5).
Gpr124 is expressed in developing ECs, and targeted mutation
of Gpr124 in mice, either throughout the body or specifically in
ECs, leads to defects in embryonic CNS angiogenesis and
BBB formation that closely resemble the defects caused by
loss of canonical Wnt signaling (Kuhnert et al., 2010; Anderson
et al., 2011; Cullen et al., 2011). Like many ‘‘adhesion GPCRs,’’
Gpr124 is currently classified as an orphan receptor since the
ligand(s) that activate it and the signal transduction pathway(s)
to which it couples are unknown. Starting with the clue that
Gpr124 is essential for CNS angiogenesis, we demonstrate
here that Gpr124 functions as a ligand-specific coactivator of
canonical Wnt signaling in the CNS vasculature during both em-
bryonic and postnatal life.
RESULTS
Gpr124 Selectively Activates Wnt7a/Wnt7b Signaling
via Fz4 and Lrp5 in a Reporter Cell Line
As an initial screen, we askedwhether transfection of a canonical
Wnt signaling reporter cell line (Super Top Flash; STF) with Lrp5
and each of the 19 mammalian Wnts or Norrin could reveal an
effect of coexpressed Gpr124 (Figure 1A). STF cells express
multiple Wnt signal transduction components at a low level
(Table S1 available online), which likely accounts for their re-
sponses to some Wnts in the absence of cotransfected Friz-
zleds, the high-affinity Wnt receptors. Gpr124 was observed to
increase Wnt7a- and Wnt7b-dependent signaling 8-fold and
4-fold, respectively (Figure 1A; Figure S1A). Gpr124 had little
or no effect on signaling by otherWnts or by Norrin. To determine
which of the tenmammalian Frizzledsmediate theGpr124 effect,
we transfected STF cells with each Frizzled together with Lrp5
andWnt7a or Wnt7b, with or without Gpr124 (Figure 1B). Among
the five Frizzleds that exhibited a signal substantially above
background, Fz1 and Fz4 showed the greatest enhancement
by Gpr124 (up to 10-fold).ier Inc.
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the closely related protein Gpr125 (Figure S1B). When Wnt7a or
Wnt7b, Fz4, and Lrp5 were cotransfected with Gpr125, we
observed an 2- to 3-fold depression in the STF signal relative
to the vector control, whereas Gpr124 produced 15-fold and
2-fold increases in Wnt7a and Wnt7b signaling, respectively
(Figure 1C). In a screen analogous to the one shown in Figure 1A
(Lrp5 and each of the 19 mammalian Wnts or Norrin), Gpr125
showed little effect on signaling (Figure S1C).
The data presented thus far are consistent with a model in
which Gpr124 promotes the formation or enhances the activity
of the Wnt/Fz/Lrp transmembrane signaling complex. Alter-
nately, Gpr124 could increase the bioactivities of Wnt7a and
Wnt7b by promoting their folding, intracellular trafficking, or
secretion. To distinguish these possibilities, we cocultured STF
cells transfected with Fz4 and Lrp5, with or without Gpr124,
together with 293 cells that had been transfected with Wnt7a
and/or Gpr124 (Figure 1D). This experiment showed that
Gpr124 had no effect on Wnt7a production/secretion by cocul-
tured 293 cells but instead exerted its effects only when ex-
pressed in STF cells, consistent with a role for Gpr124 as part
of the Fz/Lrp signaling complex.
Lrp5 and Lrp6, the closely related coreceptors for canonical
Wnt signaling (Figure S1B), are largely interchangeable in a vari-
ety of biological contexts (Joiner et al., 2013). In particular, pre-
natal CNS angiogenesis is unaffected by loss of either Lrp5 or
Lrp6 but is severely compromised by the combined loss of
both receptors (Zhou et al., 2014). Surprisingly, Gpr124 does
not enhance Wnt7a/Fz4/Lrp6 signaling in STF cells (Figure 1E,
left panel). A control experiment shows that both Lrp5 and
Lrp6 mediate Tspan12 enhancement of signaling in response
to Norrin, albeit with different levels of basal activity (Figure 1E,
right panel). In a titration experiment (Figure 1F), Lrp6 showed
noGpr124 stimulation at any dose tested, whereas each compo-
nent in the putative Wnt7a/Fz4/Lrp5/Gpr124 signaling complex
showed well-behaved dose-response curves. We note that in
the Wnt7a, Fz4, and Lrp5 titrations, Gpr124 stimulation was
observed at all concentrations tested. Earlier work demon-
strated that Lrp5 and Lrp6 differ quantitatively in signal transduc-
tion efficiency (MacDonald et al., 2011), but the difference
between Lrp5 and Lrp6 in Gpr124 responsiveness in the STF
assay is striking, as it represents an all-or-none functional differ-
ence between the two Lrp coreceptors.
The severe defects in CNS angiogenesis in Gpr124/ em-
bryos imply that loss of Gpr124 in vivo impairs both Lrp5 and
Lrp6 signaling. We tested the idea that Gpr124 might enhance
Wnt7a or Wnt7b signaling via Lrp6 in the context of Frizzleds
other than Fz4 by surveying all ten Frizzleds in STF cells. This sur-
vey revealed only a modest (2-fold) enhancement for Fz1 (Fig-
ure S1D). We hypothesize that other still-unknown components
facilitate Gpr124 stimulation of Wnt/Fz signaling via Lrp6 in
CNSECs and that these components aremissing fromSTF cells.
Current evidence indicates that Tspan12 is an integral part of
the Norrin/Fz4/Lrp5 signaling complex and that Tspan12 en-
hances Norrin-induced but not Wnt-induced canonical signaling
through Fz4 (Junge et al., 2009). To compare the ligand specific-
ities of Tspan12 and Gpr124 in the context of Fz4/Lrp5 signaling,
we measured canonical Wnt signaling in response to Wnt7a
or Norrin (Figures 1G and 1H). These experiments show thatDevelopmGpr124 enhances Wnt7a signaling but not Norrin signaling and
that Tspan12 enhances Norrin signaling but not Wnt7a signaling.
Thus, Tspan12 and Gpr124 function as ligand-specific coactiva-
tors of canonical Wnt signaling in the context of the Fz4/Lrp5
complex. The components of these two signaling complexes
are diagrammed in Figure 1I.
Gpr124 andNorrin/Fz4Play Partially Redundant Roles in
CNS Angiogenesis and BBB Development
To test whether Gpr124 participates in canonical Wnt signaling
in vivo, we examined the expression of a Tcf/Lef-nLacZ canoni-
cal Wnt signaling reporter transgene (BAT-gal; Maretto et al.,
2003) in wild-type (WT) versus Gpr124/ embryos. In the
Gpr124/ CNS between embryonic day (E)11.5 and E13.5,
the number of beta-galactosidase+ EC nuclei was dramatically
reduced in multiple regions, including the medial ganglionic
eminence (MGE), hindbrain, and spinal cord compared to WT
controls (Figures 2A and 2C; Figures S2A and S2B), indicating
a reduction in canonical Wnt signaling.
Embryos with an EC-specific knockout of beta-catenin exhibit
defective CNS angiogenesis throughout the entire neuraxis
(Stenman et al., 2008; Liebner et al., 2008; Daneman et al.,
2009; Zhou et al., 2014), whereas Gpr124/ embryos exhibit
CNS angiogenesis defects in the forebrain and ventral spinal
cord but not in the midbrain, hindbrain, or dorsal spinal cord
(Kuhnert et al., 2010; Anderson et al., 2011; Cullen et al., 2011).
In embryos lacking Wnt7a andWnt7b, the pattern of CNS angio-
genesis defects resembles the pattern seen in Gpr124/ em-
bryos (Stenman et al., 2008; Daneman et al., 2009). Intriguingly,
at midgestation, Ndp (Norrie disease protein; the gene coding for
Norrin) is expressed in the dorsal spinal cord and in the hindbrain
but is not detectable in the forebrain (Ye et al., 2011), suggesting
that Norrin/Fz4 signaling may play a complementary and/or
partially redundant role with Wnt7a/Wnt7b/Gpr124 signaling.
To test this hypothesis, we compared CNS angiogenesis in
NdpKO, Gpr124/, and Gpr124/;NdpKO embryos at E11.5
(Figures 2B–2F, S2A–S2C, and S2E; Ndp is an X-linked gene,
and we refer to both Ndp/ females and Ndp/Y males as
NdpKO). The CNS vasculature in NdpKO embryos is indistinguish-
able fromWT, and canonical Wnt signaling in ECs appears to be
normal in NdpKO embryos as judged by Tcf/Lef-nLacZ expres-
sion (Figures 2A, 2C, and S2A). Unlike NdpKO or Gpr124/ em-
bryos, Gpr124/;NdpKO embryos show a severe defect in hind-
brain vascularization with numerous glomeruloid-like vascular
bodies (Figures 2E and S2A; multiple examples are shown in
Figure S2E). Gpr124/;NdpKO embryos also show an enlarged
avascular zone in the ventral spinal cord relative to Gpr124/
embryos (Figures 2B, 2C, S2A, and S2C). These data are sum-
marized in Figure 2F and Table S2. Consistent with these archi-
tectural defects, the fraction of EC nuclei in these regions that are
beta-galactosidase+ is smaller in Gpr124/;NdpKO embryos
than in Gpr124/ embryos (Figures 2C and S2A).
Despite widespread postnatal expression of Gpr124 in CNS
and non-CNS vasculature, early postnatal and EC-specific elim-
ination of Gpr124 in Gpr124CKO/;Pdgfb-CreER mice produces
no detectable vascular phenotype in the brain or retina (Kuhnert
et al., 2010; Figures 2G, S2G, and S2H; data not shown). Consti-
tutive loss of Ndp leads to CNS vascular phenotypes that are
confined to the retina (severe hypovascularization) andental Cell 31, 248–256, October 27, 2014 ª2014 Elsevier Inc. 249
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Figure 1. Specificity of Gpr124 for Wnt7a and Wnt7b Activation of Canonical Wnt Signaling via Lrp5 and Fz4 in Transfected STF Cells
(A) Ratio of luciferase activity induced in STF cells by Wnt+Gpr124+Lrp5 compared to Wnt+vector (pRK5)+Lrp5 plotted against luciferase activity induced by
Wnt+Gpr124+Lrp5. Themeans are shown from triplicate determinations. See Figure S1A for an enlargement of the lower left part of the plot. STF cells are a stable
HEK/293 derivative that expresses firefly luciferase in response to canonical Wnt signaling (Xu et al., 2004).
(legend continued on next page)
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Gpr124 Is a Ligand-Specific Coactivatorcerebellum (a mild BBB defect), despite the expansion of the
Ndp expression domain around the time of birth to include astro-
cytes throughout the CNS in addition to Bergman glia in the cer-
ebellum and Muller glia in the retina (Ye et al., 2010). The broad
spatiotemporal expression domains observed for Ndp and
Gpr124 suggest that these genes may play wider roles in post-
natal CNS vascular development/homeostasis than previously
appreciated, but these roles may have been masked by redun-
dancy. Consistent with this idea, eliminating both Gpr124 and
Ndp postnatally in Gpr124CKO/;NdpKO;Pdgfb-CreER mice pro-
duced widespread loss of BBB integrity, as assessed by leakage
of sulfo-NHS-biotin from the intravascular space to the paren-
chyma (Figures 2G and S2F). Vascular leakage was associated
with suppression of the tight junction protein claudin5 and induc-
tion of plasmalemma vesicle-associated membrane protein
(PLVAP), a structural component of EC fenestrations. This
phenotype was observed in the cerebral cortex, hippocampus,
colliculus, brain stem, and cerebellum, but it was largely absent
from the thalamus and the roof of the anterior midbrain (Figures
2G, S2F, and S2G; data not shown). Presumably, CNS regions
that were less affected express other activators of canonical
Wnt signaling.
As a further test of the hypothesis that Gpr124 participates in
canonical Wnt signaling in vivo, we asked whether the combined
loss of Fz4 and Gpr124 produced a more severe phenotype than
loss of either gene alone (Figure 3). In midgestation embryos, Fz4
and Gpr124 are expressed throughout the CNS vasculature (Ye
et al., 2009; Kuhnert et al., 2010; Anderson et al., 2011; Cullen
et al., 2011). Fz4/ embryos have no vascular defects, and
Gpr124/ embryos survive through late gestation, despite their
CNS vascular defects. When we generated various combina-
tions of Fz4 and Gpr124 alleles, the following phenotypes were
observed (listed in order of increasing severity): (1) Fz4+/;
Gpr124+/ embryos, fetuses, and postnatal mice showed no
vascular defects; (2) Fz4/;Gpr124+/ embryos showed no
vascular defects, but postnatal Fz4/;Gpr124+/ mice showed
an enhanced conversion of cerebellar ECs from a PLVAP
to a PLVAP+ state relative to Fz4/ controls (Figure 3B); (3)
Fz4+/;Gpr124/ embryos showed variable defects in hindbrain
angiogenesis at E11.5 (Figure 3C); and (4) Fz4/;Gpr124/ em-
bryos exhibited a severe and lethal growth retardation by E10.5
(Figure 3D).
As summarized in Figure 3A, among 97 embryos harvested at
E11.5 from a Gpr124+/;Fz4+/3Gpr124+/;Fz4+/ intercross, 6
were Gpr124/;Fz4/. In this cohort, 6 of 97 embryos were
growth retarded and/or dead, and this phenotype coincided(B) Relative luciferase activity in STF cells of Wnt7a+Lrp5+Fz or Wnt7b+Lrp5+Fz
(C) Relative luciferase activity in STF cells of Gpr124 versus Gpr125 with Wnt7a
(D) Coculture of 293 cells transfected with Wnt7a, with or without Gpr124, toget
(E) Comparison ofWnt7a/Fz4/Gpr124 versus Norrin/Fz4/Tspan12 signaling and th
STF cells.
(F) Titrations of Gpr124, Wnt7a, Fz4, and Lrp5 or Lrp6 plasmids in transfected S
concentration (per three wells of a 96-well tray, these are: Gpr124, 50 ng; Fz4, 5
(G) Comparison of Gpr124 versus Tspan12 effects on Wnt7a/Fz4/Lrp5 signaling
(H) Comparison of Gpr124 versus Tspan12 effects onNorrin/Fz4/Lrp5 signaling in
Norrin-alkaline phosphatase (AP) fusion protein.
(I) Illustration of plasma membrane proteins that mediate Wnt7a or Wnt7b/Fz4/L
For (C)–(H), the data are from three replicates, and the box andwhisker plots show
percentile values (box). See also Figure S1 and Table S1.
Developmprecisely with the Gpr124/;Fz4/ genotype. If genotype and
lethality were uncorrelated, the probability of this coincidence
would be 1.36 3 106.
This dosage experiment shows that with a progressive reduc-
tion in the number of WT copies of both Gpr124 and Fz4, there
is a progressive increase in phenotypic severity. These experi-
ments also imply that Gpr124 does not act exclusively through
Fz4. If it did, then Fz4/ embryos would have a vascular
phenotype at least as severe as that of Gpr124/ embryos.
Presumably, Gpr124 also enhances canonical Wnt signaling in
ECs via one or more other Frizzleds. We note that multiple Friz-
zleds in addition to Fz4, are expressed in ECs (Goodwin et al.,
2006) and are, therefore, candidates for interacting with
Gpr124 in vivo, despite their lower synergy with Gpr124 in the
STF assay.
Artificially Activating Canonical Wnt Signaling Rescues
Vascular Defects in Gpr124–/– Embryos
All of the data presented up to this point support the hypothesis
that Gpr124 acts in the CNS vasculature by enhancing canonical
Wnt signaling. A critical test of this hypothesis would be to deter-
mine whether the vascular phenotype of Gpr124/ embryos
can be rescued by artificially increasing canonical Wnt signaling.
We have performed this test in two ways: (1) by stabilizing beta-
catenin in ECs and (2) by overexpressing Norrin in the forebrain.
Beta-catenin communicates the canonical Wnt signal from cyto-
plasm to nucleus, and its artificial stabilization—by Cre-medi-
ated excision of glycogen synthase kinase-3 phosphorylation
sites within exon 3 of the beta-catenin gene (Ctnnb1) in
Ctnnb1flex3/+;Pdgfb-CreER mice (Harada et al., 1999)—should
override canonical Wnt signaling defects at the plasma mem-
brane. The Norrin overexpression experiment, which utilizes a
Cre-activated Norrin knockin at the Ubiquitin-B locus (Z/Norrin;
Ye et al., 2009; Wang et al., 2012) and an early-embryonic-fore-
brain-specific Cre driver (Foxg1-Cre; He´bert and McConnell,
2000), tests whether expanding the domain of Norrin/Fz4
signaling in the early embryo can compensate for the loss of
Wnt/Gpr124 signaling.
Figure 4B shows that E13.5 Gpr124/ embryos exhibit fore-
brain and lower spinal cord hemorrhage (column 1; white ar-
rows), severe defects in vascularization of the MGE (columns
2–4) and cerebral cortex (columns 2, 3, and 5), and loss of
CNS vascular expression of Glucose transporter-1 (Glut-1; an
EC marker for the BBB state; columns 2–5). The beta-catenin
rescue experiment (Figures 4D, 4G, and S2D) shows that
E13.5 Gpr124/;Ctnnb1flex3/+;Pdgfb-CreER embryos—treatedwith vector (pRK5) versus Gpr124.
or Wnt7b in the presence of Fz4 and Lrp5.
her with STF cells transfected with Fz4 and Lrp5, with or without Gpr124.
eir dependence on Lrp5 versus Lrp6 determined by relative luciferase activity in
TF cells. For each titration, the three other plasmids were held at a standard
0 ng; Wnt7a, 10 ng; and Lrp5, 5 ng).
in STF cells.
STF cells. For this experiment, Norrin was delivered in conditionedmedium as a
rp5/Gpr124 and Norrin/Fz4/Lrp5/Tspan12 signaling.
themean (heavy bar), the extremes (whiskers), and the interpolated 25th to 75th
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Figure 2. Gpr124 and Ndp Are Partially Redundant in CNS Angiogenesis
(A) Canonical Wnt signaling in ECs in E12.5 MGE vasculature in WT, Gpr124/, NdpKO, and Gpr124/;NdpKO mice as measured by accumulation of a nuclear-
localized beta-galactosidase reporter expressed from the Tcf/Lef-nLacZ transgene (left panels). z-stacked images from WT and Gpr124/ MGE are shown;
white arrows, beta-galactosidase positive nuclei. Conveniently, there is little or no Tcf/Lef-nLacZ expression in neural progenitors in the MGE. Upper right:
quantification. Box and whisker plot parameters are described in the Experimental Procedures. Lower right: drawing showing the MGE in a coronal brain section
at E12.5, with the black square corresponding to the images at left. Figures S2B–S2D display the individual data points for this and other scatterplots.
(B) Avascular zone in the ventral spinal cord in Gpr124/ and Gpr124/;NdpKO embryos at E11.5. The avascular zone is absent in NdpKO embryos and is
expanded in Gpr124/;NdpKO embryos compared to Gpr124/ embryos (left panels). The neuroepithelium is outlined in red, and the dorsal boundary of the
ventral avascular zone is marked by blue lines. For quantification (right), the area of the avascular zone was compared to the area of the spinal cord.
(C) Tcf/Lef-nLacZ expression in NdpKO, Gpr124/, and Gpr124/;NdpKO spinal cord vasculature. Single z-plane images are shown; white arrows, beta-
galactosidase-positive nuclei. Figure S2A shows the corresponding z-stacked images from spinal cord and hindbrain.
(D) Locations and planes of section of E11.5 spinal cord, from (B) and (C), and hindbrain, from (E).
(E) Massive reduction in Gpr124/;NdpKO hindbrain vascularization at E11.5. NdpKO, Gpr124/, and Gpr124/;Ndp+/ hindbrains show normal or nearly
normal vascular architecture at E11.5, although Tcf/Lef-nLacZ expression is reduced in the Gpr124/ hindbrain vasculature (Figure S2A).
(F) Summary of hypovascularization and Wnt reporter phenotypes in the Gpr124/ and Gpr124/;NdpKO CNS at E11.5.
(G) Effect of EC-specific postnatal ablation of Gpr124 in an NdpKO background (Gpr124CKO/-;NdpKO;Pdgfb-CreER): many CNS ECs convert from PLVAP/
claudin5+ to PLVAP+/claudin5 with extensive sulfo-NHS-biotin leakage into the brain parenchyma (shown here for cerebral cortex). Brains from three control
genotypes are shown (WT, Gpr124CKO/;NdpKO, andGpr124CKO/;Pdgfb-CreER): CNSECs remain PLVAP/claudin5+ and sulfo-NHS-biotin leakage is confined
to the choroid plexus. Far right, vasculature within the Gpr124CKO/;NdpKO;Pdgfb-CreER thalamus is largely PLVAP/claudin5+ (white arrows). 4HT (50–100 mg)
was injected intraperitoneally at P3–P4, and brains were examined at P6.
Scale bars, 200 mm (A, B, C, and G) and 500 mm (E). See also Figure S2 and Table S2.
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Figure 3. Gpr124 and Fz4 Interact Geneti-
cally in CNS Angiogenesis and BBBMainte-
nance
(A) Genotypes and phenotypes of 97 embryos
harvested at E11.5 from 15 timed pregnant
females from a Gpr124+/;Fz4+/ 3 Gpr124+/;
Fz4+/ intercross.
(B) Fz4/ and Gpr124+/;Fz4/ cerebella at P9.
Gpr124+/;Fz4/ cerebella show accelerated
conversion of granule cell layer ECs to a PLVAP+
state (arrows).
(C) Angiogenesis in E11.5 hindbrains. Within each
image, the perineural vascular plexus is to the left
and the ventricular surface is to the right. Thewidth
of the neuroepithelium is indicated by the black line
beneath each image. Angiogenesis in Gpr124+/;
Fz4+/, Gpr124+/;Fz4/, and Gpr124/;Fz4+/+
hindbrains is indistinguishable from WT (upper
panels). Angiogenesis in Gpr124/;Fz4+/ hind-
brains is variably attenuated (lower panels). Hind-
brain sections are shown from five Gpr124/;
Fz4+/ embryos, and three show a severely im-
poverished vascular network with glomeruloid
bodies (red arrows).
(D) Severe growth retardation of Gpr124/;
Fz4/ embryos at midgestation; all embryos
were harvested at E11.5.
Scale bars, 200 mm. See also Table S2.
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tamoxifen—exhibit almost complete suppression of the fore-
brain hemorrhage but not the spinal cord hemorrhage (column
1; white arrow), partial rescue of the MGE (columns 2–4) and
cerebral cortical (columns 2, 3, and 5) vascularization defects,
and partial rescue of the Glut-1 expression defect (columns
2–5). In E13.5 Gpr124/;Ctnnb1flex3/+;Pdgfb-CreER ventral
spinal cords, vascularization is largely rescued and Glut-1
expression is partially restored (Figure S3A). The incomplete
rescue of the spinal cord hemorrhage most likely reflects
the temporal overlap between spinal cord angiogenesis,
which begins at E10, and the initiation of Pdgfb-CreER-
dependent recombination following tamoxifen administration
at E10.5. Rescue of Gpr124/;Ctnnb1flex3/+;Pdgfb-CreER
embryos did not occur without tamoxifen treatment (data
not shown).
The Norrin rescue experiment (Figure 4F and S3D) shows
that Gpr124/;Z/Norrin;Foxg1-Cre embryos exhibit a nearly
complete rescue of all Gpr124/ defects except for the spinal
cord hemorrhage, a result that is expected based on the fore-
brain-specific expression of Foxg1-Cre. When examined at
different time points, the Gpr124/;Z/Norrin;Foxg1-Cre cere-
bral cortex shows retarded vascularization at E11.5 but nearly
normal vascular architecture at E12.5 and E13, and the
Gpr124/;Z/Norrin;Foxg1-Cre MGE showed normal pericyte
coverage of the rescued vessels at E12.5, as judged by
the distribution of NG2 (Figures S3B–S3D). We note that
increasing canonical Wnt signaling on a WT background inDevelopmental Cell 31, 248–256,control Ctnnb1flex3/+;Pdgfb-CreER and
Z/Norrin;Foxg1-Cre embryos had little
or no effect on embryonic vasculardevelopment at or prior to E13.5 (Figures 4C, 4E, 4G, S3A,
S3B and S3D).
DISCUSSION
The experiments reported here establish Gpr124 as a ligand-
specific coactivator of canonical Wnt signaling in developing
and mature ECs, yet they also suggest that additional compo-
nents of this system remain to be discovered (Figure 4H). We
speculate that Gpr124 evolved to ensure a high signal-to-noise
ratio for Wnt7a- and Wnt7b-induced signaling in brain vascular
development and homeostasis, analogous to the role of
Tspan12 in the context of Norrin/Fz4 signaling. Coactivators
of canonical Wnt signaling might be especially important in
the context of CNS vascular biology because signal strength
in this system appears to be close to the minimal threshold
required for normal development and function: in both mice
and humans, modest decrements in canonical Wnt signaling
in ECs have been shown to subtly retard vascular development
and/or BBB/BRB maintenance (Nikopoulos et al., 2010; Zhou
et al., 2014).
The ligand and receptor specificities of Gpr124 might provide
a partial resolution to two apparent paradoxes: (1) that Wnt
knockout phenotypes are generally specific to particular tissues
and developmental process, whereas the distribution of individ-
ual Wnt ligands is often more widespread (http://www.stanford.
edu/group/nusselab/cgi-bin/wnt/), and (2) that the 3D structure
of a Wnt bound to a Frizzled ligand-binding domain shows thatOctober 27, 2014 ª2014 Elsevier Inc. 253
(legend on next page)
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Gpr124 Is a Ligand-Specific Coactivatormost ligand-receptor contacts involved residues (and a lipid) that
are conserved across Wnt and Frizzled family members (Janda
et al., 2012). We suggest that binding and signaling specificity
between the 19 mammalian Wnts and the ten mammalian Friz-
zleds is sharpened by coactivators such as Gpr124, allowing
cells such as ECs to exhibit greater discrimination in an environ-
ment in which multiple Wnts are competing for receptor binding.
It would be of interest to test whether other members of the
adhesion GPCR family function as coactivators in the context
of other Wnt/Frizzled combinations or of other ligand-receptor
systems.
The finding that Wnt/Gpr124 and Norrin/Fz4 function in a
largely redundant manner to maintain the BBB in postnatal life
lends support to an emerging picture of the BBB as ametastable
state of EC differentiation that is maintained by canonical Wnt
signaling (Liebner et al., 2008; Wang et al., 2012). It would be
of great interest to determine whether alterations in canonical
Wnt signaling play a role in pathologic BBB breakdown,
as observed in the contexts of neuroinflammation, stroke, and
trauma (Obermeier et al., 2013). Defining the molecules and
pathways that control BBB integrity also suggests potential stra-
tegies for transient and/or localized modulation of BBB integrity
to enhance CNS drug delivery (Paes et al., 2011).
The experiments reported here, together with the observa-
tion of high Gpr124 transcript levels in tumor vasculature
(St. Croix et al., 2000; Carson-Walter et al., 2001), implicate
canonical Wnt signaling in tumor angiogenesis. This inference
is consistent with earlier observations that Wnt antagonists
can inhibit both vascularization of tumors and differentiation
of endothelial cell progenitors (Hu et al., 2009). It seems likely
that canonical Wnt signaling in ECs activates similar proan-
giogenic programs during CNS and tumor angiogenesis.
Taken together, these data support the idea that inhibition of
canonical Wnt signaling could synergize with inhibition of
vascular endothelial growth factor signaling as an antiangio-
genic therapy.
EXPERIMENTAL PROCEDURES
Mice
The following transgenic mouse alleles were used: Gpr124CKO (JAX 016881;
Cullen et al., 2011), Tcf/Lef-nLacZ (JAX 005317; Maretto et al., 2003), NdpKO
(JAX 012287; Ye et al., 2009), Fz4 (JAX 012823; Wang et al., 2001), Z-Norrin
(JAX 011077; Ye et al., 2009), Foxg1-Cre (JAX 004337; He´bert and McConnell,
2000), Ctnnb1flex3 (Harada et al., 1999), and Pdgfb-CreER (Claxton et al.,
2008). Mice were handled and housed according to the approved Institutional
Animal Care and Use Committee protocol MO13M469 of the Johns Hopkins
Medical Institutions.
Antibodies
Antibodies used in this study were as follows: chicken anti-beta-galactosidase
(Abcam 9361); rabbit anti-GLUT-1 (Thermo Fisher Scientific RB-9052-P0);Figure 4. Gpr124–/– CNS Angiogenesis Defects Can Be Rescued by Ar
(A–F) E13.5 embryos. The horizontal white line in (A, column 1) shows the plane o
fourth and fifth columns. Scale bars in columns 2 and 3, 500 mm; scale bars in c
(G) Quantification of vascular density in the cerebral cortex at E13.5. Box and wh
(H) Summary of interacting ligand, receptor, coreceptor, and coactivator combi
integrity. In the retina, Lrp6 plays a minor role, and it is therefore shown in parent
signaling, and it is therefore shown in parentheses. Unknown Wnts and Frizzleds
represented by X?.
See also Figure S3 and Table S2.
Developmrabbit anti-NG2 (Millipore AB5320); rat anti-mouse CD102/ICAM2 (BD Biosci-
ences 553326); rat anti-PLVAP/ MECA-32 (BD Biosciences 553849); mouse
anti-Claudin-5, Alexa Fluor 488 conjugate (Invitrogen 352588), and Texas
Red streptavidin (Vector Laboratories SA-5006). Alexa Fluor-labeled second-
ary antibodies and GS lectin (Isolectin GS-IB4) were from Invitrogen. Primary
antibodies were used at 1:200 to 1:500 dilution.
Luciferase Assays
Luciferase assays were performed as described by Xu et al. (2004).
Tissue Processing and Immunohistochemistry
Tissue processing was performed as described byWang et al. (2012) and Zhou
et al. (2014).
RNA Sequencing of STF Cells
RNA was extracted from STF cells using Trizol (Life Technologies) and purified
with the RNeasy kit (QIAGEN). The complementary DNA library was synthe-
sized using the TrueSeq kit (Illumina) and sequenced from one end on an Illu-
mina HiSeq, with read lengths of 50 bases. A total of 103,453,057 reads were
obtained, of which 103,441,162 could be aligned to the human genome (hg19)
using TopHat (v2.0.8). Transcript abundance (fragments per kilobase of tran-
script per million mapped reads) was quantified using Cufflinks (v2.1.1).
Graphical Presentations
Box and whisker plots (RStudio) show the median (heavy horizontal bar) and
the 25th–75th percentiles (box). The whiskers are located at the positions of
the furthest flung data points above or below the mean that are within a dis-
tance of 1.5 times the 25th–75th percentile distance (i.e., height of the box)
either below the 25th percentile position or above the 75th percentile position.
Any data points beyond the whiskers are plotted individually. A detailed
description of the Experimental Procedures is presented in the Supplemental
Information.
ACCESSION NUMBERS
The Gene Expression Omnibus accession numbers for the RNA sequencing
data reported in this paper are GSE60529 and GSM1481718.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and two tables and can be found with this article online at
http://dx.doi.org/10.1016/j.devcel.2014.08.018.
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